BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27267375)

  • 1. Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.
    Welsh KJ; Bai Y;
    Am J Clin Pathol; 2016 Jun; 145(6):744-51. PubMed ID: 27267375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice.
    Ramsey G;
    Arch Pathol Lab Med; 2009 Mar; 133(3):465-9. PubMed ID: 19260751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists.
    Hartwell EA
    Am J Clin Pathol; 1998 Sep; 110(3):281-92. PubMed ID: 9728602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined flow cytometry-based method for fetomaternal hemorrhage and maternal D.
    Radel DJ; Penz CS; Dietz AB; Gastineau DA
    Transfusion; 2008 Sep; 48(9):1886-91. PubMed ID: 18513253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.
    Rushin J; Rumsey DH; Ewing CA; Sandler SG
    Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and Follow-up of Massive Fetomaternal Hemorrhage Requiring High-Dose Rh Immune Globulin: A Case Report.
    Fortes PA; Gnass ED; Baez J; Bayati B; Mei Z; McGonigle AM; Ziman A; Ward DC
    Am J Clin Pathol; 2023 Jul; 160(1):78-80. PubMed ID: 36897771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
    Aitken SL; Tichy EM
    Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective quantification of fetomaternal hemorrhage with dilation and evacuation procedures.
    Hsia JK; Schimmoeller NR; Cansino CD; Hou MY; Jensen HM; Creinin MD
    Contraception; 2019 May; 99(5):281-284. PubMed ID: 30500335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis.
    Kumpel B; Hazell M; Guest A; Dixey J; Mushens R; Bishop D; Wreford-Bush T; Lee E
    Transfusion; 2014 May; 54(5):1305-16. PubMed ID: 24236535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin.
    Nester TA; Rumsey DM; Howell CC; Gilligan DM; Drachman JG; Maier RV; Kyles DM; Matthews DC; Pendergrass TW
    Transfusion; 2004 Dec; 44(12):1720-3. PubMed ID: 15584986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of asymptomatic massive fetomaternal hemorrhage.
    Peedin AR; Mazepa MA; Park YA; Weimer ET; Schmitz JL; Raval JS
    Transfus Apher Sci; 2015 Apr; 52(2):208-10. PubMed ID: 25736586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Rh sensitization in the context of trauma: two case reports.
    Werch JB
    J Clin Apher; 2010; 25(2):70-3. PubMed ID: 20027640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG.
    Ayache S; Herman JH
    Transfusion; 2008 Sep; 48(9):1990-9. PubMed ID: 18564395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetrics and gynecology physician knowledge of Rh immune globulin prophylaxis.
    Yu A; Morris E; Adams R; Fung MK
    Transfusion; 2017 Jun; 57(6):1385-1390. PubMed ID: 28419453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory methods for Rh immunoprophylaxis: a review.
    Sandler SG; Sathiyamoorthy S
    Immunohematology; 2010; 26(3):92-103. PubMed ID: 21214295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD).
    Anderson B; Shad AT; Gootenberg JE; Sandler SG
    Am J Hematol; 1999 Mar; 60(3):245-7. PubMed ID: 10072121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically silent massive fetomaternal hemorrhage: important lessons from an illustrative case.
    Post GR; Lazarchick J; Singh ZN
    Lab Hematol; 2012 Jun; 18(2):11-3. PubMed ID: 22709788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages.
    Ness PM; Salamon JL
    Am J Clin Pathol; 1986 May; 85(5):604-6. PubMed ID: 3085471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.